A detailed history of New York State Common Retirement Fund transactions in Pds Biotechnology Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 2,191 shares of PDSB stock, worth $6,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,191
Previous 931 135.34%
Holding current value
$6,463
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$3.85 - $6.59 $4,851 - $8,303
1,260 Added 135.34%
2,191 $9,000
Q4 2023

Feb 01, 2024

SELL
$3.95 - $6.58 $63,014 - $104,970
-15,953 Reduced 94.49%
931 $5,000
Q3 2023

Nov 07, 2023

BUY
$4.8 - $6.4 $1,363 - $1,817
284 Added 1.71%
16,884 $85,000
Q2 2023

Aug 07, 2023

BUY
$5.03 - $9.9 $83,498 - $164,340
16,600 New
16,600 $83,000

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $84M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.